Karkinos Healthcare has an early mover advantage in self-sustainable cancer care and offers a unique value proposition backed by over three hundred years of combined clinical expertise.
Initial results demonstrate the ability of the technology Distributed Cancer Care Network (DCCN) system to successfully screen and detect cancer and to converge the actions of various private health facilities towards providing a continuum of cancer care. The lessons learnt from this study will be useful for replicating the process in other States.
Molecular profiling has a strong influence on every aspect of cancer care including detection, diagnosis, staging and therapy response assessment. Recent advances in the understanding of cancer biology have prompted the introduction of new targeted therapy approaches.